title: Ulcerative dermatitis, thrombocytopenia, and neutropenia in neonatal foals.
abstract: This report describes transient ulcerative dermatitis, severe thrombocytopenia, and mild neutropenia in 6 foals from 4 mares from geographically diverse regions of the United States. The foals presented at <4 days of age with oral and lingual ulcers, and crusting and erythema around the eyes, muzzle, and perineal, inguinal, axillary, trunk, and neck regions. There was a severe thrombocytopenia (0-30,000 platelets/microL), leukopenia (1900-3200 white blood cells/microL), and mild neutropenia (500-1800 neutrophils/microL). Four of the 6 foals had petechiae and ecchymotic hemorrhages and 3 had bleeding tendencies. Results of examination of a bone marrow biopsy from 1 foal were normal and results of a platelet surface immunoglobulin test in another were negative. Histopathology of the skin in all foals showed subepidermal clefting with subjacent vascular dilation, dermal hemorrhage, and superficial papillary necrosis. The foals were treated supportively with broad-spectrum antibiotics (5/6), corticosteroids (3/6), gastric ulcer prophylaxis (6/6), whole-blood transfusion (4/6), and platelet-rich plasma (1/6). The skin lesions and thrombocytopenia (>50,000 platelets/microL) improved in 2 weeks (4/6). Two foals had a decline in their platelet counts when the steroids were decreased and needed protracted treatment. All foals survived and were healthy as yearlings. Two mares that had 2 affected foals each, upon subsequent pregnancies to different stallions, had healthy foals when an alternate source of colostrum was given. The findings in the cases in this report suggest a possible relationship between colostral antibodies or some other factor in the colostrum and the thrombocytopenia and skin lesions, although further investigation is warranted to confirm or refute this hypothesis.
authors.affiliation: Department of Clinical Sciences, New York State College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA. gap7@cornell.edu
authors.forename: G A
authors.initials: GA
authors.lastname: Perkins
authors.forename: W H
authors.initials: WH
authors.lastname: Miller
authors.forename: T J
authors.initials: TJ
authors.lastname: Divers
authors.forename: C K
authors.initials: CK
authors.lastname: Clark
authors.forename: R L
authors.initials: RL
authors.lastname: Belgrave
authors.forename: D C
authors.initials: DC
authors.lastname: Sellon
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000831:Animals, Newborn; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001803:Blood Transfusion / Q000662:veterinary; D003126:Colostrum; D003872:Dermatitis / Q000188:drug therapy / Q000662:veterinary*; D005260:Female; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006734:Horse Diseases / Q000097:blood* / Q000473:pathology*; D006736:Horses; D009503:Neutropenia / Q000188:drug therapy / Q000662:veterinary*; D012189:Retrospective Studies; D013577:Syndrome; D013921:Thrombocytopenia / Q000188:drug therapy / Q000662:veterinary*; D013997:Time Factors
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D006635:Histamine H2 Antagonists